✦ LIBER ✦

Pharmacogenomics in Cardiovascular Medicine

✍ Scribed by John F. Carlquist; Jeffrey L. Anderson

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 115 KB
Volume: 62
Category: Article
ISSN: 0272-4391
DOI: 10.1002/ddr.10355

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nanotechnology in cardiovascular medicin

Nanotechnology in cardiovascular medicine

✍ Devang N. Patel; Steven R. Bailey 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 966 KB

## Abstract Nanotechnology is a new field of science and technology that has already had significant impact in the development of novel products in industry. In medicine, application of nanotechnology has the potential to develop new imaging agents, pharmaceutical drugs and medical devices with uni

MicroRNA therapeutics in cardiovascular

MicroRNA therapeutics in cardiovascular medicine

✍ Thomas Thum 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

Women in interventions: A win for cardio

Women in interventions: A win for cardiovascular medicine

✍ Steven R. Bailey 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

“THE UNVEILED HEART” a teaching program

“THE UNVEILED HEART” a teaching program in cardiovascular nuclear medicine

✍ Roland Itti; Yasmina Merabet; Ramona Roca; Laurence Bontemps; Emmanuel Itti 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Role of pharmacogenomics in drug develop

Role of pharmacogenomics in drug development

✍ Hakon Hakonarsson; Kari Stefansson 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

Pharmacogenomics in sepsis and septic sh

Pharmacogenomics in sepsis and septic shock

✍ David Shaw; James A. Russell; Keith R. Walley 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB